Open AccessIn silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors
Author(s) -
Sagar D. Magar,
Pratap Y. Pawar
Publication year - 2022
Publication title -
international journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns3.9448
Subject(s) - in silico , chemistry , lipinski's rule of five , docking (animal) , egfr inhibitors , combinatorial chemistry , drug , computational biology , pharmacology , t790m , mutant , epidermal growth factor receptor , biochemistry , receptor , biology , gene , gefitinib , medicine , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom